Clinically studied UK GMP Launch preparation

The science behind T-Booster

The thymus can recover.That insight inspiredT-Booster.

We studied the thymus’s natural recovery biology and asked whether daily nutrition could support thymus function and new T-cell output as we age.

THYMUS RECOVERYNATURAL REPAIR INSPIRED THE RESEARCH
NEW T-CELL OUTPUTFOCUSED ON NEWLY GENERATED T CELLS
IMMUNE AGEINGDESIGNED AROUND THYMUS AGEING
HUMAN STUDYBIOMARKERS AND PARTICIPANT FEEDBACK

01 · Why we began

COVID-19 revealed whythe thymus mattered.

Older adults faced a much higher risk from COVID-19 than younger people. That contrast directed our attention towards immune ageing and the organ that helps produce new T cells.

A dynamic organ
01Pressure
02Temporary shrinkage
03Recovery

Stress, infections, pregnancy and some cancer treatments can temporarily shrink the thymus. When the pressure passes, natural repair can begin.

01

Age revealed the challenge

COVID-19 outcomes showed how strongly age can affect the body’s ability to respond to a new threat.

02

The thymus became the focus

The thymus helps produce new T cells. Its activity is generally stronger when we are young and declines as we age.

03

Recovery provided the clue

After temporary shrinkage, the thymus can activate natural repair processes when the pressure has passed.

04

The biology shaped T-Booster

We studied those recovery pathways and natural compounds that may support them, leading to an 18-ingredient daily formulation.

Scientific basis and original papers

These papers support the biological rationale for studying immune ageing, thymic involution and thymic recovery. They do not by themselves establish a product-specific clinical effect; conclusions about T-Booster depend on the completed human-data analysis.

02 · What the thymus does

The thymus trains T cellsfor flexible immunity.

Inside the thymus, immature immune cells are trained, tested and selected. The cells that succeed leave as mature T cells, helping the body maintain a broad and flexible immune repertoire.

A biological training environment

A training ground for new T cells

Immature cells arrive from the bone marrow and receive a carefully ordered sequence of biological signals.

Useful cells are retained, unsuitable or self-reactive cells are removed, and the successful cells enter circulation prepared to recognise unfamiliar infections and abnormal cells.

Anatomical illustration showing the thymus between the lungs
Biological focusThe thymus supports T-cell development and selection.
  1. 01

    Training

    Signals guide immature cells towards functional T-cell identities.

  2. 02

    Selection

    The thymus removes unsuitable cells and retains useful responders.

  3. 03

    Diversity

    The resulting repertoire gives the immune system more ways to recognise unfamiliar threats.

See the biology in motion

Watch how the thymus trains new T cells.

The animation follows immature cells as they arrive, train and are selected inside the thymus. The selected cells leave the thymus, enter the bloodstream and travel through the body as mature T cells.

Artistic scientific illustration of a mature T cell travelling among red blood cells inside a blood vessel.
Mature T cells enter circulation.

03 · A dynamic organ

The thymus changeswith age and stress.

The thymus gradually becomes less active with age. It can also contract temporarily under pressures such as infection, severe stress, pregnancy and some cancer treatments, before recovering when that pressure passes.

Chart showing functional thymic activity declining across age groups from infancy to later adulthood
  1. 01

    Early life

    High thymic activity supports a broad supply of newly generated T cells.

  2. 02

    Across adulthood

    Natural thymic involution gradually reduces the rate of new T-cell production.

  3. 03

    Under biological pressure

    Temporary shrinkage can occur during infection, stress, pregnancy and some treatments—and recovery may follow when that pressure resolves.

04 · From question to formulation

Research shaped an18-ingredient formulation.

The aim was not to choose one fashionable ingredient. Over four years of R&D, 13 researchers and specialists reviewed the biology, available human evidence, ingredient compatibility, practical dosing and UK GMP manufacturing.

18selected ingredients
4years of R&D
13researchers and specialists
  1. 01Begin with thymus biology and healthy immune ageing
  2. 02Select complementary minerals, vitamins and nutraceuticals
  3. 03Review dose, compatibility, safety and manufacturing practicality
  4. 04Move from a biological proposal to outcomes that can be measured in people
Formulation overview showing 2 minerals, 5 vitamins and 11 nutraceuticals combining into an 18-ingredient T-Booster capsule

05 · Turning the idea into evidence

A biological idea matterswhen it can be measured.

The programme was designed to look beyond personal impressions. It combines a molecular marker, wider blood context, participant experience and a blinded placebo comparison.

  1. 01
    Molecular marker

    TREC DNA

    A marker associated with newly generated T cells provides biological context for thymic output.

  2. 02
    Blood context

    CBC and lymphocytes

    Wider blood measures help place the principal biological findings in context.

  3. 03
    Participant experience

    18-question questionnaire

    Volunteers recorded everyday health concerns at baseline and again during the programme.

  4. 04
    Study design

    Blinded placebo comparison

    The randomised, double-blind, placebo-controlled programme involved 260 adults.

06 · Where the programme stands

Full data will answerthe biology question.

The rationale is defined, the formulation has been developed, and human participation is complete. Laboratory analysis and statistical interpretation will determine what the programme can responsibly conclude.

  1. 01

    Research question defined

    The programme connects thymus function, newly generated T cells and healthy immune ageing.

  2. 02

    Natural formulation developed

    Eighteen selected ingredients were developed through a UK GMP manufacturing route.

  3. 03

    Human participation completed

    The randomised, double-blind, placebo-controlled programme involved 260 adults over 12 months.

The next chapter

See how the question was tested in people.

Explore the study design, participant journey and outcomes used to evaluate the formulation.

View the clinical study